South Korea — Ministry of Food and Drug Safety
Tracked across 2 events · 13 articles · First seen May 26, 2026 · Last active Jun 02, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Lundbeck announced that the South Korea — Ministry of Food and Drug Safety of South Korea has granted marketing authorization for eptinezumab (Vyepti) for the preventive treatment of migraine in adults. This approval is a…
Impact: The South Korea — Ministry of Food and Drug Safety granted the marketing authorization for eptinezumab in South Korea.
May 26, 2026 · 7 articles
Regulatory
Santhera Pharmaceuticals announced that its drug AGAMREE has received Orphan Drug Designation (ODD) and Global Innovative Products on Fast Track (GIFT) designation from South Korea's South Korea — Ministry of Food and Drug Safety for…
Impact: The South Korea — Ministry of Food and Drug Safety in South Korea granted the Orphan Drug Designation and Global Innovative Products on Fast Track designation to AGAMREE, which will expedite its regulatory review.
Jun 02, 2026 · 6 articles
100
South Korea — Ministry of Food and Drug Safety granted marketing authorization LundbeckH. Lundbeck receives South...
NEWSDESK
Track South Korea — Ministry of Food and Drug Safety live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard